Medicinova Inc
MNOV - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$68.88M
Close$
$0.62
55.4% downside
Current Fair Value
55.4% downsideOvervalued by 55.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $68.88 Million |
|---|---|
| Enterprise Value | $40.77 Million |
| Earnings per Share | $-0.24 |
| Beta | 0.61 |
| Outstanding Shares | 49,378,238 |
Return
| Return on Equity | -6340.69% |
|---|---|
| Return on Assets | -5759.37% |
| Return on Invested Capital | -21.60% |
Valuation & Multiples
| P/E Ratio | -6.42 |
|---|---|
| PEG | 6.43 |
| Price to Sales | 0.47 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.22 |
| Enterprise Value to EBIT | -4.54 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 12, 2026
EPS
-$0.06
Est. -$0.06Revenue
$138,555
Est. $50,000Next Earnings Call
Expected Date
February 19, 2027
EPS Estimate
-$0.09
Consensus analyst estimateRevenue Estimate
$33,333
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 14.92%▲ 4.26% |
|---|---|
| Total Invested | $12.31M▲ 77.59% |
| Investors Holding | 28▼ 2.00% |
About Medicinova Inc
6 employees
CEO: Yuichi Iwaki
MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases...